APA (7th ed.) Citation

U, K., J, H., C, L., D, D. M., N, I., N, P., . . . D, D. (2020). Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy. Alimentary pharmacology & therapeutics, 52(1), 135. https://doi.org/10.1111/apt.15784

Chicago Style (17th ed.) Citation

U, Kopylov, et al. "Effectiveness of Ustekinumab Dose Escalation in Crohn's Disease Patients with Insufficient Response to Standard-dose Subcutaneous Maintenance Therapy." Alimentary Pharmacology & Therapeutics 52, no. 1 (2020): 135. https://doi.org/10.1111/apt.15784.

MLA (9th ed.) Citation

U, Kopylov, et al. "Effectiveness of Ustekinumab Dose Escalation in Crohn's Disease Patients with Insufficient Response to Standard-dose Subcutaneous Maintenance Therapy." Alimentary Pharmacology & Therapeutics, vol. 52, no. 1, 2020, p. 135, https://doi.org/10.1111/apt.15784.